SVS Medical LLC is seeking candidates for C-Level Position

SVS Medical LLC announced today that it is actively searching for qualified, experienced healthcare candidates to consider joining the company.
NEW YORK - July 30, 2016 - PRLog -- SVS Medical LLC announced today that it is actively recruiting new potential candidates for C-Level positions within the newly venture funded company. Specifically, the company wishes to consider candidates qualified in healthcare with a focus on either the medical device, pharmaceutical packaging or pharmaceutical manufacturing experience. Moreover, the company seeks to enact an equity-sharing structure through divesting stock to the new candidates upon completion of tangible milestones for the business and its subsidiaries, BioFaran Laboratories S.A. and Eulysis Inc.

Among the actively sought after candidate positions are the position of CEO and CTO. While Prof. Dr. S Tsakas II (Ross) considers himself a suitable President, he is confident these moves will spark renewed potential for the enterprise. "It is my hope that suitable candidates will reach out to us and join our team to help truly reach every person with the medicines and treatments they need on a global scale. We began this dream to fulfill philanthropic initiatives and spotlight injustices in health equality and equitable access. We can no longer wait while the perils of global health deterioration have begun to emerge."

For the roles, it is preferable to create a brief covering letter and attach a CV of no longer than two pages with relevant experience, education and pertinent information. While the process might take a while to conclude, the team is hopeful it will create a foundation to propel and launch the technologies to their true heights.

Speaking about his envisaged prospects for the business:

"I want to ensure that there are fully donated vaccines and medicines to all developing countries. There really is no need to satisfy specific criteria. Where there is a demand and need, we will provide the SVS and related technologies free of charge. We cannot control what the pharmaceutical manufacturer will charge in terms of their API stored within the SVS but anticipate corporate goodwill matching our gestures. While the need to satisfy investor return on investment is quintessential, we must balance this with a healthy demand in developed countries."

In 2014, Eulysis Inc., the subsidiary of SVS Medical LLC which developed the Single Vial System (SVS) technology, was profiled in a publication related to the potential for SVS to mitigate the recent outbreak of Ebola. Now, the company's Founder is committed to ensuring this takes place soon.

"If we act soon, all the plans might pan out in a manner that equates to enhanced pharmaceutical access globally with a win-win situation for all parties across the supply chain. We need to save children from crippling illness so they may go to school and get good jobs. We need mothers to be able to work and provide for their children and we need similar commitments from fathers and all family/community members. Without health, we are trapping the world in a perpetual cycle of misery and poverty."

Founder Prof. Dr. S Tsakas II has been profiled and won multiple awards since conceiving the SVS solution which offers twice as many medicines at half the cost globally. Among these are the Grand Challenges Initiative from the Bill & Melinda Gates Foundation, an Enterprise Fellowship from the Royal Society of Edinburgh, account management by Scottish Enterprise as one of the Highest Potential New Companies of Scotland and the Growth Fund from HRH Prince Charles' Prince's Trust. He is an active philanthropist, entrepreneur and academic, world renowned for his devotion to improving global health for all.

For more information, please visit www.svsmedical.com or contact Founder Ross Tsakas via e-mail at rt@svsmedical.com.

Contact
Prof. Dr. S Tsakas II 'Ross'
rt@svsmedical.com
7744639947
End
Source: » Follow
Email:***@svsmedical.com Email Verified
Tags:Ceo, C-level, New Ventures
Industry:Biotech
Location:New York City - New York - United States
Subject:Executives
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share